Seaport Therapeutics, Inc. Common Stock (SPTX) — Financial Flexibility Index
Seaport Therapeutics, Inc. Common Stock (SPTX) has a Financial Flexibility Index of -0.23x as of December 2025. Free cash flow of $-77.59 Million (operating CF $-77.94 Million minus capex $356.00K) represents 0% of total liabilities ($341.55 Million). Check financial resilience of Seaport Therapeutics, Inc. Common Stock to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Seaport Therapeutics, Inc. Common Stock Financial Flexibility Index (2024–2025)
Historical Financial Flexibility Index trend for Seaport Therapeutics, Inc. Common Stock across 2 annual periods. See Seaport Therapeutics, Inc. Common Stock working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Seaport Therapeutics, Inc. Common Stock (2024–2025)
Year-by-year free cash flow to debt coverage for Seaport Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see SPTX market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.23x | $-77.59 Million | $-77.94 Million | $341.55 Million | ▼ -162.1% |
| 2024 | -0.09x | $-29.52 Million | $-29.63 Million | $340.63 Million | — |